Press ReleasesKanabo Announces Formation Of New Subsidiary, Which Has Signed...

Kanabo Announces Formation Of New Subsidiary, Which Has Signed MOU For Spanish Indoor Cultivation Project


KANABO Group Plc. (LON: KNB), a medical cannabis R&D Company that focuses on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers, announces it has formed a new, partly owned, subsidiary to monetise the Company’s Intellectual Property and that the new subsidiary has signed its first Memorandum of Understanding (“MoU”) for an indoor medical cannabis cultivation project in Spain.

Kanabo Agritec Ltd

Kanabo Group plc has formed an Israeli subsidiary company, Kanabo Agritec Ltd. (“Agritec”), which Kanabo Research Ltd, a wholly owned subsidiary of Kanabo Group plc., holds a 40% shareholding together with certain additional control rights over the strategic direction of the subsidiary

Agritec’s sole purpose is to enter into agreements with third parties at minimal cost to leverage the Company’s Intellectual Property for the cultivation, processing, and production of cannabis products.

The strategic rationale for Kanabo is twofold:

· Firstly, Agritec provides Kanabo with complementary near-term revenue opportunities

· Secondly , Agritec will offer Kanabo improved security of cannabis supply through a diverse range of suppliers, who will all adopt Kanabo’s high-quality manufacturing standards without Kanabo having to fund or become directly involved in cannabis cultivation.

Agritec’s three other shareholders are co-founders Ophir Shimshi and Eilon Bdil, experts in Cannabis regulation and cultivation and R. P. Growing Technologies Ltd., who each hold 20% of the issued share capital in Agritec.

R.P. Growing Technologies Ltd, is a Group of companies, which includes Grow Tec Innovations Ltd (2018) & We Can Dry Ltd (2018), which are both experienced in agricultural technology projects, providing a wide range of services, from planning, designing, engineering and/or manufacturing as well as complete turnkey projects and high-level agricultural projects in field of medical Cannabis.

Agritec, will be able to offer customers turnkey consulting services relating to the:

· Procurement, design and build of commercial scale medical cannabis cultivation facilities

· Supply high-quality genetics and standard operating procedures for optimal medical cannabis cultivation

· Provide post-harvest services including offtake agreements with Kanabo Group plc

· Design and draft reporting and documentation filing services with the local authorities

· Provide local training and ongoing consulting services

First MoU for a 4,000kg Indoor Medical Cannabis Production Project in Spain

Agritec has signed its first MoU for the design, build and operation of a 4,000kg per annum indoor cultivation and processing facility in Madrid, Spain. The proposed facility is to be focused exclusively on medical cannabis.

As per the terms of the MoU, Agritec may may elect to receive up to 20% ownership of the Project based on the achievement of agreed milestones.

Latest news

Germany Seeing Sense, High Tide Strikes Deal With Major German Player, European Expansion For Bedrocan, Danish Buy-Out, Greek First, £2m UK Hemp Boost

THE German Government’s refreshingly honest approach to drugs and addiction is being demonstrated with a focus on the harms...

European Cannabis Stocks Review: Akanda Announces ‘First Significant Revenue Above Initial Projections’, Jazz Pharma Reimbursement Recommendation & Kanabo Climbs

Akanda  Akanda has enjoyed a sharp recovery in its share price this week, seeing its value return to levels not...

15% Of European Consumers Have Tried CBD, But Industry Held Back By ‘High Turnover Rate’ Of Users

THE European CBD market is set to see a ‘massive influx’ of previous and new consumers to the market...

Malta’s Pioneering Legal Cannabis Club Framework Announced, But Concerns Raised Licence Fees Could Push Many To Black Market

ON Friday (January 27) the Maltese Authority for the Responsible Use of Cannabis (ARUC) announced new guidelines set to...

Cannovum AG Establishes Cultivation Alliance For Germany

PRESS RELEASE CANNOVUM AG is currently founding the premier cultivation alliance for recreational cannabis in Germany. The aim of the...

Jazz Pharmaceuticals Receives NICE Recommendation For The Reimbursement Of Epidyolex (Cannabidiol) For The Treatment Of Seizures Associated With Tuberous Sclerosis Complex In England

PRESS RELEASE JAZZ Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Epidyolex® (cannabidiol,100 mg/mL oral solution), developed by GW Pharmaceuticals ("GW"; now...

Must read

You might also likeRELATED
Recommended to you